The Potential Benefit of Metformin to Reduce Delirium Risk and Mortality
A new research paper was published in Aging (listed as “Aging (Albany NY)” by MEDLINE/PubMed and “Aging-US” by Web of Science) Volume 14, Issue 22, entitled, “The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study.” Metformin has been reported to improve age-related disorders, including dementia, and to lower mortality. This study was conducted to investigate whether metformin use lowers delirium risk, as well as long-term mortality. In the current retrospective cohort study, researchers Takehiko Yamanashi, Zoe-Ella EM Anderson, Manisha…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.